Emerging GLP-1 receptor agonists.

  title={Emerging GLP-1 receptor agonists.},
  author={Asger Lund and Filip Krag Knop and Tina Vilsb\oll},
  journal={Expert opinion on emerging drugs},
  volume={16 4},
INTRODUCTION Recently, glucagon-like peptide-1 receptor (GLP-1R) agonists have become available for the treatment of type 2 diabetes. These agents exploit the physiological effects of GLP-1, which is able to address several of the pathophysiological features of type 2 diabetes. GLP-1R agonists presently available are administered once or twice daily, but several once-weekly GLP-1R agonists are in late clinical development. AREAS COVERED The present review aims to give an overview of the… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…